03:12 AM EST, 02/03/2025 (MT Newswires) -- Craig C. Hopkinson, Executive Vice President, Research & Development, Chief Medical Officer, on January 30, 2025, sold 100,918 ordinary shares in Alkermes ( ALKS ) for $3,234,382. Following the Form 4 filing with the SEC, Hopkinson has control over a total of 44,290 shares of the company, with 44,290 shares held directly. SEC...

ROME (Reuters) - EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its over-the-counter Nuance audio glasses. Nuance - which pairs hearing solutions with prescription glasses - will be available in the U.S. and in Italy in the first quarter of the year and in other European countries, including France, Germany...

03:10 AM EST, 02/03/2025 (MT Newswires) -- Eric P Lefkofsky, 10% Owner, Director, Chief Executive Officer and Chairman, on January 29, 2025, sold 238,800 Class A common shares in Tempus AI ( TEM ) for $13,278,632. Following the Form 4 filing with the SEC, Lefkofsky has control over a total of 48,757,318 shares of the company, with 5,532,987 shares held...

03:09 AM EST, 02/03/2025 (MT Newswires) -- Steven Leonard Chapman, Director, Chief Executive Officer and President, on January 29, 2025, sold 13,685 common shares in Natera ( NTRA ) for $2,269,928. Following the Form 4 filing with the SEC, Chapman has control over a total of 253,944 shares of the company, with 253,944 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1604821/000141588925002621/xslF345X05/form4-01312025_090101.xml ...